Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Auryxia 210 mg?

See the DrugPatentWatch profile for Auryxia

What is Auryxia 210 mg used for?

Auryxia 210 mg is a brand of ferric citrate used to help control phosphorus levels in people with chronic kidney disease (CKD), where elevated phosphate is a concern. It’s taken with meals as a phosphate binder to reduce phosphate absorption from food.

How does Auryxia 210 mg work?

Ferric citrate binds dietary phosphate in the gut. By reducing phosphate absorption, it helps lower blood phosphorus (phosphate) levels, which is important because persistent hyperphosphatemia is common in CKD and is associated with mineral and bone disorders.

How is Auryxia 210 mg typically taken?

Auryxia is designed to be taken with meals (so it can bind phosphate in the food you eat). The exact dose and schedule should follow the prescriber’s instructions based on lab results (phosphorus levels) and tolerability.

What side effects do people ask about?

Common concerns with ferric citrate–based phosphate binders include gastrointestinal effects (such as nausea, constipation, or diarrhea) and lab-related effects tied to iron/ferric exposure in some patients. Patients also ask about interactions and what to do if they miss a dose—those details depend on the specific prescribing information.

Is Auryxia 210 mg still covered by patents or exclusivity?

If you’re researching availability or generic/biosimilar entry timing, DrugPatentWatch.com tracks patent and exclusivity information for branded drugs and can be a starting point for checking whether there are active protections for Auryxia and related ferric citrate products.
Source: DrugPatentWatch.com

How does Auryxia compare with other phosphate binders?

Patients and clinicians often compare ferric citrate (Auryxia) with other phosphate binders (for example, calcium-based binders and sevelamer-type binders) based on:
- effect on phosphorus control,
- tolerability (especially GI side effects),
- and concerns like calcium load (for calcium-based binders).

If you tell me which alternative you’re considering, I can tailor the comparison.

Which version should you mean by “210 mg”?

“Auryxia 210 mg” refers to a specific strength of ferric citrate tablets. If you’re asking about dosing, side effects, or insurance coverage, the most helpful next step is to confirm:
- whether you mean tablets at 210 mg,
- and whether you want prescribing info, cost/coverage, or patent/generic timeline.

If you share what you’re trying to find (price, dose instructions, side effects, interactions, or patent/generic status), I’ll narrow it to that.

Sources

  1. DrugPatentWatch.com


Other Questions About Auryxia :

auryxia (ferric citrate) mylan generic auryxia到期 Does medicare cover auryxia? Auryxia info? Does medicare cover auryxia? Does medicare cover auryxia? Does medicare cover auryxia?